Feature Channels: Liver Disease

Filters close
Released: 16-May-2022 1:20 PM EDT
New Report From Mercy Medical Center, Center for Therapeutic Endoscopy - Purely Endoscopic Appendectomy
Mercy Medical Center

Dr. Sergey V. Kantsevoy, Director of The Center for Therapeutic Endoscopy at Mercy Medical Center in Baltimore, MD, in conjunction with his colleagues at The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy, have reported the first purely endoscopic appendectomy.

5-May-2022 4:05 PM EDT
Scientists Study Links Between Obesity, Age and Body Chemistry
Clemson University

Scientists make inroads in understanding the relationship between certain enzymes that are normally produced in the body and their role in regulating obesity and controlling liver diseases.

Newswise: UTSW Geneticist Jonathan Cohen Elected to the National Academy of Sciences
Released: 4-May-2022 12:05 AM EDT
UTSW Geneticist Jonathan Cohen Elected to the National Academy of Sciences
UT Southwestern Medical Center

The National Academy of Sciences (NAS) today elected UT Southwestern scientist Jonathan Cohen, Ph.D., into its membership, one of the highest honors for American scientists. Dr. Cohen, Professor of Internal Medicine in the Center for Human Nutrition and the Eugene McDermott Center for Human Growth and Development at UT Southwestern, was elected by his peers in recognition of distinguished and continuing achievements in original research. His research centers on identifying genes that play major roles in the metabolism of cholesterol and triglycerides and elucidating the biological roles of their protein products.

Released: 3-May-2022 1:05 PM EDT
Study sheds light on the benefits of exercise in fatty liver disease
University of Eastern Finland

Exercise supports the treatment of non-alcoholic fatty liver disease by impacting on several metabolic pathways in the body, a new study from the University of Eastern Finland shows.

Released: 18-Apr-2022 2:45 PM EDT
Nanotherapeutics for hepatocellular carcinoma treatment
Bentham Science Publishers

Nanotherapeutics have shed new light onto HCC treatment by enabling site-specific in vivo delivery of chemotherapeutics specifically to neoplastic hepatocytes without affecting normal hepatocytes.

Released: 7-Apr-2022 2:45 PM EDT
Kisspeptin: A New Drug to Treat Liver Disease?
Rutgers University-New Brunswick

A hormone that triggers puberty and controls fertility in humans might be developed as a treatment for non-alcoholic fatty liver disease, according to new Rutgers research.

Newswise: The Medical Minute: The connection between alcohol and liver transplantation
Released: 6-Apr-2022 8:05 PM EDT
The Medical Minute: The connection between alcohol and liver transplantation
Penn State Health

Since the start of the COVID-19 pandemic, alcohol use has been on the rise ― and so is alcohol-associated liver disease. Two Penn State Health doctors discuss what alcohol does to the liver and when it’s time for a transplant in this week’s Medical Minute.

Newswise: Mini-livers on a chip
Released: 6-Apr-2022 3:35 PM EDT
Mini-livers on a chip
Gladstone Institutes

A vaccine for hepatitis C has eluded scientists for more than 30 years, for several reasons.

Newswise: Donate Life Month Tipsheet: Experts From the Cedars-Sinai Comprehensive Transplant Center
Released: 6-Apr-2022 11:50 AM EDT
Donate Life Month Tipsheet: Experts From the Cedars-Sinai Comprehensive Transplant Center
Cedars-Sinai

Throughout the month of April—Donate Life Month—experts from Cedars-Sinai Comprehensive Transplant Center and the Smidt Heart Institute are available for interviews on issues related to transplantation, immunology and organ donation.

Released: 5-Apr-2022 3:55 PM EDT
The latest news on clinical trials is here on Newswise
Newswise

Here are some of the latest articles that have been added to the Clinical Trials channel on Newswise.

25-Mar-2022 9:00 AM EDT
Researchers Uncover How Sugar Substitutes Disrupt Liver Detoxification
Federation of American Societies for Experimental Biology (FASEB)

Results from a new study suggest that two sugar substitutes disrupt the function of a protein that plays a vital role in liver detoxification and the metabolism of certain drugs. These sugar substitutes, also known as non-nutritive sweeteners, provide a sweet taste with few or no calories.

Released: 4-Apr-2022 10:05 AM EDT
Expert Alert: 5 reasons to consider becoming an organ donor
Mayo Clinic

While 2021 proved to be a record-breaking year for organ donation in the U.S., many people are still hesitant to register to become a donor. Nationwide, only about 48% of people are registered to be organ donors, according to LifeSource. That's despite surveys showing that 95% of people in the U.S. support organ donation.

Newswise: New Guidelines on Barrett’s Esophagus and Antithrombotics During GI Bleeding Featured in the April Issue of The American Journal of Gastroenterology
Released: 4-Apr-2022 9:00 AM EDT
New Guidelines on Barrett’s Esophagus and Antithrombotics During GI Bleeding Featured in the April Issue of The American Journal of Gastroenterology
American College of Gastroenterology (ACG)

The April issue of The American Journal of Gastroenterology includes two new guidelines—an update to the 2016 guidelines on Barrett’s Esophagus and a joint society guideline on the management of antithrombotics during GI bleeding and the periendoscopic period.

25-Mar-2022 9:00 AM EDT
Mineral Supplement Could Stop Fatty Liver Disease Progression
Federation of American Societies for Experimental Biology (FASEB)

Results from a preclinical study add new evidence that a multi-mineral dietary supplement known as Aquamin could be a simple and effective way to reduce the long-term health consequences of non-alcoholic fatty liver disease. Aquamin, which is derived from calcified red marine algae, is rich in calcium, magnesium and 72 other minerals and trace elements.

Released: 25-Mar-2022 9:30 AM EDT
Experimental Biology 2022 Press Materials Available Now
Federation of American Societies for Experimental Biology (FASEB)

Embargoed press materials are now available for the Experimental Biology (EB) 2022 meeting, featuring cutting-edge research from across the life sciences. EB 2022, to be held April 2–5 in Philadelphia, is the annual meeting of five scientific societies bringing together thousands of scientists and 25 guest societies in one interdisciplinary community.

15-Mar-2022 1:00 PM EDT
No-Click System Doubles Hepatitis C Screening Orders, Study Finds
Perelman School of Medicine at the University of Pennsylvania

Hepatitis screening rates climbed to 80 percent for patients whose doctors didn’t need to opt in to order a screening

Released: 11-Mar-2022 1:25 PM EST
Media Advisory: Mayo Clinic experts to discuss recent advances in gastroenterology at Abu Dhabi conference
Mayo Clinic

Mayo Clinic experts will discuss recent advances in gastroenterology and hepatology at the first Mayo Clinic International-Sheikh Shakhbout Medical City Congress in Gastroenterology and Hepatology in Abu Dhabi, United Arab Emirates.

Released: 9-Mar-2022 5:25 PM EST
إخطار إعلامي: خبراء مايو كلينك يناقشون التطورات الحديثة في طب الجهاز الهضمي في مؤتمر بمدينة أبوظبي
Mayo Clinic

سيناقش خبراء مايو كلينك التطورات الحديثة في طب الجهاز الهضمي والكبد في مؤتمر مايو كلينك الدولي الأول في مدينة الشيخ شخبوط الطبية لطب الجهاز الهضمي والكبد في أبوظبي، الإمارات العربية المتحدة. وقد دخلت مايو كلينك وشركة أبوظبي للخدمات الصحية "صحة" في مشروع مشترك عام 2019 لتشغيل مدينة الشيخ شخبوط الطبية.

Released: 9-Mar-2022 12:00 PM EST
MD Anderson Research Highlights for March 9, 2022
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current findings include immunotherapy advances for AML, liver cancer, HPV-related cancers and other solid tumors, biomarkers of response to TIL therapy in melanoma, a greater understanding of the cells regulating skin wound repair, and data confirming the safety of proton therapy for pediatric brain cancer.

Released: 4-Mar-2022 4:05 PM EST
A new study relates liquid fructose intake to fatty liver disease
University of Barcelona

A high-fat diet is not enough to cause short-term fatty liver disease. However, if this diet is combined with the intake of beverages sweetened with liquid fructose, the accumulation of fats in the liver accelerates and hypertriglyceridemia —a cardiovascular risk factor— can appear.

1-Mar-2022 9:00 AM EST
Women with irregular periods may be at risk for liver disease
Endocrine Society

Women with long or irregular periods are known to have a higher risk of type 2 diabetes and heart disease, but researchers found these women may also be at risk for nonalcoholic fatty liver disease (NAFLD), according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism.

Newswise: Physical activity reduces clotting risk in patients with nonalcoholic fatty liver disease
Released: 28-Feb-2022 7:05 AM EST
Physical activity reduces clotting risk in patients with nonalcoholic fatty liver disease
Penn State College of Medicine

Exercise may help certain patients with nonalcoholic fatty liver disease reduce their risk of developing blood clots, according to a new study by Penn State College of Medicine researchers.

Newswise: UT Southwestern researcher, international team solve decades-old structural mystery surrounding the birth of energy-storing lipid droplets
Released: 25-Feb-2022 12:20 PM EST
UT Southwestern researcher, international team solve decades-old structural mystery surrounding the birth of energy-storing lipid droplets
UT Southwestern Medical Center

In humans, virtually every cell stores fat. However, patients with a rare condition called congenital lipodystrophy, which is often diagnosed in childhood, cannot properly store fat, which accumulates in the body’s organs and increases the risk of early death from heart or liver disease. In 2001, a transmembrane protein called seipin was identified as a molecule essential for proper fat storage, although its mechanism has remained unknown.

Released: 22-Feb-2022 4:05 PM EST
Diseased male livers undergo sex-change
University of Queensland

The livers of men diagnosed with hepatic diseases change sex as part of a potential self-protective mechanism, according to University of Queensland research.

17-Feb-2022 3:35 PM EST
The Latest Research News in Cardiovascular Health
Newswise

The Latest Research News in Cardiovascular Health

Newswise: New Study Reveals Potential Target for Alcohol-Associated Liver Disease
Released: 22-Feb-2022 4:05 AM EST
New Study Reveals Potential Target for Alcohol-Associated Liver Disease
Cedars-Sinai

Investigators at Cedars-Sinai have uncovered a new pathway that helps explain how consuming too much alcohol causes damage to the liver, specifically mitochondrial dysfunction in alcohol-associated liver disease. The discovery can also help lead to a new treatment approach for people suffering from the disease.

Newswise: Hepatitis C Patients Cured with Antiviral Medicines are Less Likely to be Hospitalized, Need ER Care for Liver, Other Health-Related Issues
Released: 18-Feb-2022 4:00 PM EST
Hepatitis C Patients Cured with Antiviral Medicines are Less Likely to be Hospitalized, Need ER Care for Liver, Other Health-Related Issues
Henry Ford Health System

Researchers at Henry Ford Health System, as part of a national hepatitis C collaborative, report that patients with chronic hepatitis C who are treated with direct-acting antiviral medicines are less likely to be hospitalized or seek emergency care for liver and non-liver related health issues. The study, published online in Clinical Infectious Diseases, underscores the extraordinary effect of these newer antivirals, which have been shown to cure hepatitis C in 98 percent of patients who take them. Patients are said to be cured when the virus is no longer detectable in their blood.

Released: 15-Feb-2022 2:05 PM EST
Estudo descobre que pacientes com cirrose relacionada ao consumo de álcool têm piores resultados na recuperação de doenças graves, em comparação aos outros pacientes com cirrose
Mayo Clinic

Pacientes com cirrose relacionada ao consumo de álcool (ALC) têm piores resultados após receberem alta do tratamento intensivo, em comparação aos pacientes com cirrose associada a outras causas, de acordo com a nova pesquisa da Mayo Clinic.

Released: 15-Feb-2022 2:05 PM EST
Estudio descubre que los pacientes con cirrosis por alcohol se recuperan de una enfermedad grave con peores resultados que los demás pacientes con cirrosis
Mayo Clinic

Los resultados de los pacientes con cirrosis por alcohol (ALC, por sus siglas en inglés) después de recibir el alta de cuidados intensivos son peores que los de los pacientes con cirrosis por otras causas, dice un nuevo estudio de Mayo Clinic.

Released: 15-Feb-2022 2:05 PM EST
研究发现,相比其他类型的肝硬化患者,酒精性肝硬化患者从危重症恢复的结局更差
Mayo Clinic

根据妙佑医疗国际(Mayo Clinic) 的新研究,相比其他病因的肝硬化患者,酒精性肝硬化(ALC)患者从重症监护室出院后的恢复结局较差。

Released: 15-Feb-2022 2:05 PM EST
دراسة تجد أن المرضى المصابين بتشمع الكبد المرتبط بالكحول لديهم نتائج أسوأ في التعافي من أي مرض خطير، مقارنة بمرضى تشمع الكبد الآخرين
Mayo Clinic

ولاية مينيسوتا- يعاني مرضى تشمع الكبد المرتبط بالكحول من نتائج أسوأ بعد الخروج من العناية المركزة، مقارنةً بمرضى تشمع الكبد المرتبط بأسباب أخرى، وفقًا لبحث جديد من مايو كلينك.

14-Feb-2022 7:05 AM EST
Study shows a new scoring system can help clinicians predict 30-day mortality risk for patients with alcohol-associated hepatitis
Mayo Clinic

Mayo Clinic researchers have developed a new scoring system to help health care professionals predict the 30-day mortality risk for patients with alcohol-associated hepatitis, and the tool appears to more accurately identify patients at highest risk of death and those likely to survive.

Newswise: Rare Insight: A New Approach Optimizes Hepatoblastoma Cancer Treatment
Released: 14-Feb-2022 5:05 PM EST
Rare Insight: A New Approach Optimizes Hepatoblastoma Cancer Treatment
Children's Hospital Los Angeles

A new study at Children’s Hospital Los Angeles independently verified the value of a system that assesses hepatoblastoma risk in children. Hepatoblastoma is a rare childhood liver cancer, usually seen within the first three years of a child’s life with 50 to 70 cases occurring in the U.S. each year.

Released: 9-Feb-2022 9:00 AM EST
InSphero Further Strengthens Scientific Advisory Board for Liver Diseases by Appointing Professor Nikolai Naoumov
InSphero

InSphero AG, the pioneer in 3D cell-based assay and organ-on-chip technology, today announced the strengthening of its Scientific Advisory Board (SAB) with the appointment of Professor Nikolai Naoumov, MD PhD.

Newswise: Henry Ford Health System Study Finds Admissions for Alcoholic Hepatitis Rose 50 Percent in Early Months of the Pandemic
Released: 8-Feb-2022 11:45 AM EST
Henry Ford Health System Study Finds Admissions for Alcoholic Hepatitis Rose 50 Percent in Early Months of the Pandemic
Henry Ford Health System

In new research published in Liver International, researchers at Henry Ford Health System have found that people hospitalized for alcoholic hepatitis – a life threatening liver disease fueled by alcohol use – increased a staggering 50 percent in the early months of the COVID-19 pandemic. Researchers said the role of gender and race had no meaningful impact on the spike in admissions.

Released: 7-Feb-2022 12:45 PM EST
In Mice, Mothers with Metabolic Syndrome Can ‘Turn On’ Offspring’s Liver Disease
North Carolina State University

An imprinted gene associated with development of non-alcoholic fatty liver disease (NAFLD) is switched on in mice who nurse from mothers with metabolic syndrome, even when those mice are not biologically related.

Newswise: Answers from an Expert: Gallbladder and Bile Duct Cancer
Released: 7-Feb-2022 12:10 PM EST
Answers from an Expert: Gallbladder and Bile Duct Cancer
Rutgers Cancer Institute of New Jersey

Miral Sadaria Grandhi, MD, surgical oncologist in the Liver Cancer and Bile Duct Cancer Program at Rutgers Cancer Institute of New Jersey and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more about gallbladder and bile duct cancer.

Newswise: Blog-Photo-Lennon.jpg
Released: 7-Feb-2022 8:05 AM EST
A New Liver–and Life—for Lennon
Children's Hospital Los Angeles

Diagnosed with acute liver failure and her health rapidly deteriorating, it seemed like 11-month-old Lennon would need a miracle to survive. Thanks to a team of specialists at Children’s Hospital Los Angeles, she just celebrated her third birthday.

Newswise: Sleep Position and Reflux, New Acute-on-Chronic Liver Failure Guidelines Highlighted in February Issue of The American Journal of Gastroenterology
Released: 4-Feb-2022 9:00 AM EST
Sleep Position and Reflux, New Acute-on-Chronic Liver Failure Guidelines Highlighted in February Issue of The American Journal of Gastroenterology
American College of Gastroenterology (ACG)

The February issue of AJG includes new ACG Clinical Guidelines on acute-on-chronic liver failure, the College’s first set of guidelines on a condition that is emerging as a major cause of mortality among patients with cirrhosis and CLD.

24-Jan-2022 12:55 PM EST
Study finds that patients with alcohol-associated cirrhosis have worse outcomes in recovering from critical illness, compared with other cirrhosis patients
Mayo Clinic

Patients with alcohol-associated cirrhosis have poorer outcomes after ICU discharge, compared to patients with cirrhosis linked to other causes, according to new Mayo Clinic research.

Released: 24-Jan-2022 7:05 AM EST
Looking for Acute Liver Failure Biomarkers in Children
Children's Hospital Los Angeles

Acute liver failure (ALF) happens very quickly, with few warning signs before a child presents in the emergency room. But there are also few reliable predictors of a child’s outcome. That makes it challenging for physicians to know when it’s best to move forward with a liver transplant—and when it’s best to wait.

18-Jan-2022 5:10 PM EST
Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells
Mount Sinai Health System

Immunotherapy given before surgery caused liver cancer tumors to die off in one-third of the patients enrolled in a first-of-its-kind clinical trial, Mount Sinai researchers reported in The Lancet Gastroenterology & Hepatology in January.

Released: 17-Jan-2022 9:05 PM EST
NUS researchers identify novel pathways responsible for liver cancer
National University of Singapore

A team of NUS researchers from Cancer Science Institute of Singapore has identified new pathways responsible for hepatocellular carcinoma (HCC), the most common type of primary liver cancer. The new insights could potentially improve treatment for patients.

Newswise: UT Southwestern develops nanotherapeutic to ward off liver cancer
Released: 14-Jan-2022 9:00 AM EST
UT Southwestern develops nanotherapeutic to ward off liver cancer
UT Southwestern Medical Center

Physician researchers from UT Southwestern Medical Center have developed an innovative nanotherapeutic drug that prevents cancer from spreading to the liver in mice.

Released: 12-Jan-2022 12:00 PM EST
MD Anderson Research Highlights for January 12, 2022
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include an anti-CD19 chimeric antigen receptor (CAR) T cell therapy to treat follicular lymphoma, targeted therapies for urothelial cancers and advanced breast cancers, understanding the tumor microenvironment and immune landscape in pancreatic cancer, a link between depression risk and androgen deprivation for prostate cancer, and the discovery of new therapeutic targets for Alzheimer’s disease, liver cancer and aggressive breast cancer.

Released: 11-Jan-2022 1:05 PM EST
New Acute-on-Chronic Liver Failure Guidelines from the American College of Gastroenterology
American College of Gastroenterology (ACG)

The American College of Gastroenterology has just released new clinical guidelines on Acute-on-Chronic Liver Failure, an emerging major cause of mortality. The ACG Media Team can connect you with the authors or outside experts who can comment on the guidelines upon request.

16-Dec-2021 7:05 AM EST
Study Disentangles Genetic and Environmental Influences on Progression from Alcohol Use Disorder to Related Medical Conditions
Research Society on Alcoholism

A new study has shown that alcohol-related diseases are driven by both environmental and genetic factors, a proportion of which are not shared with the underlying alcohol use disorder (AUD).

Released: 7-Dec-2021 3:55 PM EST
A New Strategy to Transform Liver Cancer Immunotherapy
University of California San Diego Health

UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.

Released: 6-Dec-2021 3:45 PM EST
Spaceflight wreaks havoc on liver metabolism
University of Tsukuba

The latest findings of a series of studies on mice that examined harmful effects caused by spending time in space show that gene expression related to liver metabolism is altered in response to the space environment.


Showing results

150 of 443

close
0.64676